Richard Vosser

Stock Analyst at JP Morgan

(3.36)
# 404
Out of 5,441 analysts
13
Total ratings
Success rate
Average return
6 Stocks
Name Action PT Current % Upside Ratings Updated
SNY Sanofi
Upgrades: Overweight
n/a
n/a n/a 2 Aug 8, 2025
MOR MorphoSys
Maintains: Overweight
10 9
18.96 -55.17% 3 Dec 5, 2023
MOLN Molecular Partners
Maintains: Neutral
7 5
3.47 29.68% 1 Dec 5, 2023
NVO Novo Nordisk
Upgrades: Overweight
n/a
n/a n/a 5 Jun 7, 2022
UCBJY UCB
Upgrades: Overweight
n/a
n/a n/a 1 Sep 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
n/a
n/a n/a 1 Feb 23, 2021